sc13g
 

     
 
OMB APPROVAL
  
 
OMB Number: 3235-0145
  
 
Expires: February 28, 2009
  
 
Estimated average burden hours per response...10.4
  
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )*

Mindray Medical International Limited
(Name of Issuer)
Class A Ordinary Shares**
Class B Ordinary Shares**
American Depository Shares
(Title of Class of Securities)
602675100
(CUSIP Number)
December 31, 2006
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     o Rule 13d-1(b)

     o Rule 13d-1(c)

     þ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

** Not for trading, but only in connection with the registration of American Depositary Shares each representing 1 ordinary share. See footnote 1 for further discussion of shares held by Reporting Persons.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

 

                     
CUSIP No.
  
602675100 
   Page  
2 
   of   
8 

 

           
1   NAMES OF REPORTING PERSONS:
Xu Hang
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
  (a)   o
  (b)   þ
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  People's Republic of China
       
  5   SOLE VOTING POWER:
     
NUMBER OF   22,016,7581
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   22,016,7582
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  22,016,758
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  20.8%3
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  IN
 
1 These shares represent Class B ordinary shares which are not listed for trading. Holders of Class A ordinary shares and Class B ordinary shares have the same rights except for voting and conversion rights. Each Class A ordinary share is entitled to one vote on all matters subject to shareholder vote, and each Class B ordinary share is entitled to five votes on all matters subject to shareholder vote, and each Class B ordinary share is entitled to five votes on all matters subject to shareholder vote. Each Class B ordinary share is convertible at the option of the holder into one Class A ordinary share at any time by the holder thereof. Class A ordinary shares are not convertible into Class B ordinary shares under any circumstance. Class B ordinary shares will automatically and immediately convert into an equal number of Class A ordinary shares upon transfer to any person or entity which is not an affiliate of transferor.
2 See footnote 1 above.
3 Assumes conversion of all Class B ordinary shares into the same number of Class A ordinary shares.

 

                     
CUSIP No.
  
602675100 
   Page  
3 
   of   
8 

 

           
1   NAMES OF REPORTING PERSONS:
New Dragon (No. 12) Investments Limited
   
  I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): 
   
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
  (a)   o
  (b)   þ
     
3   SEC USE ONLY:
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION:
   
  Cayman Islands
       
  5   SOLE VOTING POWER:
     
NUMBER OF   22,016,7584
       
SHARES 6   SHARED VOTING POWER:
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER:
REPORTING    
PERSON   22,016,7585
       
WITH: 8   SHARED DISPOSITIVE POWER:
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
   
  22,016,758
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
   
  20.8%6
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
   
  CO
 
4 Includes 22,016,758 Class B ordinary shares.
5 See footnote 5 above.
6 Assumes conversion of all Class B ordinary shares into the same number of Class A ordinary shares.

 

                     
CUSIP No.
  
602675100 
   Page  
4 
   of   
8 
     
Item 1(a)
   Name of Issuer:
 
    
 
   Mindray Medical International Limited (“Issuer”)
 
    
Item 1(b)
   Address of Issuer’s Principal Executive Offices:
 
    
 
   Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057,
 
   People’s Republic of China
 
    
Item 2(a)
   Name of Person Filing:
 
    
 
   Xu Hang
 
    
 
   New Dragon (No. 12) Investments Limited
 
    
Item 2(b)
   Address of Principal Business Office or, If None, Residence; Citizenship
 
    
 
   Xu Hang
 
   c/o Mindray Medical International Limited
 
   Mindray Building, Keji 12th Road South, Hi-tech Industrial Park,
 
   Nanshan, Shenzhen, 518057
 
   People’s Republic of China
 
    
 
   New Dragon (No. 12) Investments Limited
 
   Ugland House,
 
   P.O.Box 309, George Town,
 
   Grand Cayman, Cayman Islands
 
    
 
    
Item 2(c)
   Citizenship
 
    
 
   Xu Hang — PRC
 
    
 
   New Dragon (No. 12) Investments Limited — Cayman Islands
 
    
Item 2(d)
   Title of Class of Securities:
 
    
 
   Class A ordinary shares, par value HK$0.001
 
    
 
   Class B ordinary shares, par value HK$0.001
 
    
 
   American Depository Shares
 
    
Item 2(e)
   CUSIP Number:
 
    
 
   602675100
 
    
Item 3.
   Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c):
 
    
 
   Not applicable.

 

 

                     
CUSIP No.
  
602675100 
   Page  
5 
   of   
8 
     
Item 4.
   Ownership
 
    
 
   (a)          Amount Beneficially Owned:
                                                 
                            Shared              
                    Sole power     power to     Sole power to     Shared power  
    Amount             to vote or     vote or to     dispose or to     to dispose or to  
    beneficially     Percent     direct     direct     direct the     direct the  
Reporting person   owned:     of class:     the vote:     the vote:     disposition of:     disposition of:  
Xu Hang
     22,016,758       20.8 %     22,016,758       0       22,016,758       0  
 
   ordinary           ordinary           ordinary        
 
   shares           shares           shares        
 
                                                
New Dragon (No. 12)
     22,016,758       20.8 %     22,016,758       0       22,016,758       0  
Investments Limited
   ordinary           ordinary           ordinary        
 
   shares           shares           shares        
The above table assumes conversion of all Class B ordinary shares into the same number of Class A ordinary shares.
New Dragon (No. 12) Investments Limited, a Cayman Islands company, is the record owner of 22,016,758 ordinary shares of the Issuer. Mr. Xu Hang is the sole shareholder of New Dragon (No. 12) Investments Limited. Pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Mr. Xu Hang may be deemed to beneficially own all of the shares held by New Dragon (No. 12) Investments Limited.
     
Item 5.
  Ownership of Five Percent or Less of a Class
 
    
 
  Not applicable.
 
    
Item 6.
  Ownership of More Than Five Percent on Behalf of Another Person
 
    
 
  Not applicable.
 
    
Item 7.
  Identification and Classification of Subsidiary Which Acquired the Security Being
 
  Reported on by the Parent Holding Company or Control Person
 
    
 
  Not applicable.
 
    
Item 8.
  Identification and Classification of Members of the Group
 
    
 
  Not applicable.
 
    
Item 9.
  Notice of Dissolution of Group
 
    
 
  Not applicable.
 
    
Item 10.
  Certifications
 
    
 
  Not applicable.

 

 

                     
CUSIP No.
  
602675100 
   Page  
6 
   of   
8 
SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. In addition, by signing below, the undersigned agrees that this Schedule 13G may be filed jointly on behalf of each of the Reporting Persons.
Dated: February 14, 2007
         
 
      Xu Hang
 
        
 
      /s/ Xu Hang
 
       
 
        
 
      New Dragon (No. 12) Investments Limited
 
        
 
  By:   /s/ Xu Hang
 
       
 
  Name:   Xu Hang
 
  Title:   Director

 

 

                     
CUSIP No.
  
602675100 
   Page  
7 
   of   
8 
LIST OF EXHIBITS
     
Exhibit No.   Description
A
  Joint Filing Agreement

 

 

EXHIBIT A
Joint Filing Agreement
     In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A and Class B Ordinary Shares, par value HK$0.001, of Mindray Medical International Limited, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which, taken together, shall constitute one and the same instrument.
         
    Xu Hang
 
        
    /s/ Xu Hang
     
 
        
 
      New Dragon (No. 12) Investments Limited
 
        
 
  By:   /s/ Xu Hang
 
       
 
  Name:   Xu Hang
 
  Title:   Director